Comparison of the Efficacy and Safety of Transarterial-Chemoembolization versus Radiofrequency-Ablation for Hepatocellular Carcinoma within Milan Criteria: A Propensity Score-Matching Study.

J Hepatocell Carcinoma · 2025 · PMC12744593 · PMID 41467096

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

did not reach statistical significancep=0.15not close (p > 0.1)

The cumulative 1-, 3-, and 5-year OS rates were 81.2%, 48.1%, and 37.1% in the TACE group versus 88.6%, 65.6%, and 54.6% in the RFA group, although this difference did not reach statistical significance (p=0.15, Figure 2c ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.